Elias AD - Search Results

1

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Hunt M, Critchlow J, Schnipper L, Frei E 3rd, et al. Elias AD, et al. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S208-13. doi: 10.1007/BF01613229. J Cancer Res Clin Oncol. 1991. PMID: 1795009 Clinical Trial.

2

Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research.

Strauss GM, Langer MP, Elias AD, Skarin AT, Sugarbaker DJ. Strauss GM, et al. Among authors: elias ad. J Clin Oncol. 1992 May;10(5):829-38. doi: 10.1200/JCO.1992.10.5.829. J Clin Oncol. 1992. PMID: 1314892 Review.

3

Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer.

Lynch TJ Jr, Clark JR, Kalish LA, Fallon BG, Elias AD, Skarin A, Frei E 3rd. Lynch TJ Jr, et al. Among authors: elias ad. Cancer. 1992 Oct 1;70(7):1880-5. doi: 10.1002/1097-0142(19921001)70:7<1880::aid-cncr2820700713>3.0.co;2-3. Cancer. 1992. PMID: 1326396

4

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, et al. Elias AD, et al. Blood. 1992 Jun 1;79(11):3036-44. Blood. 1992. PMID: 1350229 Free article.

5

The clinical management of soft tissue sarcomas.

Elias AD. Elias AD. Semin Oncol. 1992 Feb;19(1 Suppl 1):19-25. Semin Oncol. 1992. PMID: 1411616 Review.

6

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.

Seiden MV, Elias A, Ayash L, Hunt M, Eder JP, Schnipper LE, Frei E 3rd, Antman KH. Seiden MV, et al. Bone Marrow Transplant. 1992 Jul;10(1):57-63. Bone Marrow Transplant. 1992. PMID: 1515880

7

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Ayash LJ, Wright JE, Tretyakov O, Gonin R, Elias A, Wheeler C, Eder JP, Rosowsky A, Antman K, Frei E 3rd. Ayash LJ, et al. J Clin Oncol. 1992 Jun;10(6):995-1000. doi: 10.1200/JCO.1992.10.6.995. J Clin Oncol. 1992. PMID: 1588381

8

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: two protocols.

Elias AD, Mazanet R, Wheeler C, Anderson K, Ayash L, Schwartz G, Tepler I, Pap S, Pelaez J, Hunt M, et al. Elias AD, et al. Breast Cancer Res Treat. 1991 Dec;20 Suppl:S25-9. doi: 10.1007/BF01908241. Breast Cancer Res Treat. 1991. PMID: 1687204

9

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, et al. Antman K, et al. J Clin Oncol. 1992 Jan;10(1):102-10. doi: 10.1200/JCO.1992.10.1.102. J Clin Oncol. 1992. PMID: 1727912 Clinical Trial.

10

A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.

Eder JP, Elias AD, Ayash L, Wheeler CA, Shea TC, Schnipper LE, Frei E 3rd, Antman KH. Eder JP, et al. Among authors: elias ad. Cancer Chemother Pharmacol. 1991;29(1):61-5. doi: 10.1007/BF00686337. Cancer Chemother Pharmacol. 1991. PMID: 1742850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters